Back to today’s briefing

Story perspectives

£1.2M Study Aims to Unlock Semaglutide's Brain Benefits

1/30/2025

42 3

Summary

Story summary

A groundbreaking £1.2 million project has been initiated by scientists at the University of Aberdeen and University College London to explore semaglutide, a weight-loss drug notorious for its nausea side effects. Spearheaded by Professors Lora Heisler and Stefan Trapp, this research seeks to unravel the drug's brain mechanisms, paving the way for more effective pill-based treatments.

1 of 1

Story summary

A groundbreaking £1.2 million project has been initiated by scientists at the University of Aberdeen and University College London to explore semaglutide, a weight-loss drug notorious for its nausea side effects. Spearheaded by Professors Lora Heisler and Stefan Trapp, this research seeks to unravel the drug's brain mechanisms, paving the way for more effective pill-based treatments.